Disease Markers

High Resolution Omics for Biomarker Discovery


Publishing date
01 Mar 2023
Status
Closed
Submission deadline
11 Nov 2022

Lead Editor

1Zhongnan Hospital of Wuhan University, Wuhan, China

2Harvard University, Boston, USA

3Beijing Friendship Hospital, Capital Medical University, Beijing, China

This issue is now closed for submissions.

High Resolution Omics for Biomarker Discovery

This issue is now closed for submissions.

Description

High-resolution omics, such as single-cell sequencing, cytometry by time-of-flight, spatial transcriptomics, and multiplexed imaging, have provided an unprecedented opportunity for accelerated biomarker discovery and subsequent clinical translation. Although accumulating research efforts are being made, the utilization of high-resolution omics for biomarker discovery and successful translation are yet to flourish. Furthermore, important issues throughout the pipeline of high-resolution omics-based biomarker discovery which involves sample preparation, data pre-processing, data integration, and result interpretation, are to be addressed and discussed.

In this Special Issue, we welcome submissions focusing on high-resolution omics as tools for biomarker discovery across healthcare and biology disciplines. We welcome original research and review articles.

Potential topics include but are not limited to the following:

  • High-resolution omics for cancer biomarker discovery
  • High-resolution omics for aging biomarker discovery
  • High-resolution omics for surgery biomarker discovery
  • High-resolution omics for cardiovascular disease biomarker discovery
  • High-resolution omics for bone health biomarker discovery
  • High-resolution omics for respiratory disease biomarker discovery
  • High-resolution omics for infectious disease biomarker discovery
  • High-resolution omics for neurological biomarker discovery
  • High-resolution omics for gynecological biomarker discovery
  • High-resolution omics for biomarker discovery in miscellaneous healthcare disciplines
  • Innovation in high-resolution omics data science
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.